Skip to content
Disclosery

Maple-Brown Abbott Ltd: EXC position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Maple-Brown Abbott Ltd on EXC, newest first. How the timeline and the estimate are built.

Maple-Brown Abbott Ltd held 3,154,588 EXC shares at 2025-03-31 per its 13F-HR filed 2025-05-13.

the latest 13F is the newest step

  1. period ended2025-03-31
    13F 3,154,588 shares
    Change vs previous 13F +846,358 shares

    9.91% of the 13F portfolio, value $145,375,079.

    13F-HR 0001681596-25-000005 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2024-12-31
    13F 2,308,230 shares
    Change vs previous 13F -23,480 shares

    10.6% of the 13F portfolio, value $86,916,401.

    13F-HR 0001681596-25-000002 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2024-09-30
    13F 2,331,710 shares
    Change vs previous 13F -21,600 shares

    9.37% of the 13F portfolio, value $94,480,890.

    13F-HR 0001681596-24-000016 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-06-30
    13F 2,353,310 shares
    Change vs previous 13F +64,760 shares

    8.59% of the 13F portfolio, value $81,471,592.

    13F-HR 0001681596-24-000006 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-03-31
    13F/A 2,288,550 shares
    Change vs previous 13F -61,030 shares

    8.79% of the 13F portfolio, value $85,957,939.

    13F-HR/A 0001681596-24-000012 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2023-12-31
    13F/A 2,349,580 shares
    Change vs previous 13F +646,710 shares

    8.59% of the 13F portfolio, value $84,349,922.

    13F-HR/A 0001681596-24-000010 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2023-09-30
    13F/A 1,702,870 shares
    Change vs previous 13F not available

    7.38% of the 13F portfolio, value $64,377,001.

    13F-HR/A 0001681596-24-000009 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).